Skip to content
The Nexus
DossierENTITY

US business

Coverage of US business in the Nexus archive.

Earliest in view: Aug 3 · 12:30 UTCMost recent: Aug 3 · 12:30 UTC
Co-mentioned in this coverage
WuXi AppTecorganization1weight-loss drugstopic1diabetes drugstopic1Bloombergorganization1Shanghaiplace1
Recent coverage
  • BUSINESSAug 3 · 12:30 UTCSCMP CHINA
    Chinese biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny

    Wuxi AppTec, Asia’s largest contract pharmaceutical research provider, reported a 33.7% year-on-year increase in first-half net profit to 11.08 billion yuan, driven by strong demand for weight-loss and diabetes drugs and growth in its US business. The company’s earnings exceeded Bloomberg analysts’ expectations.

US business · Dossier · The Nexus